...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell

Narmac

Could it be that the failed hedge fund is still liquidating its position in RVX? I just started to look for that transcript from DM but then decided not to go down another rabbit hole. I was going to follow it up with comments on the RVX valuation recently commissioned for the Sheik investment which yielded an enterprise value far in excess of the current market price,  but that's another rabbit hole. Oh, and the fact that the  market value did not even consider the Covid market, another rabbit hole, and the fact that RVX has been given BTD status by the FDA and BTD's are typically valued at billions of $s, another rabbitt hole. Instead of chasing rabbits, I'm gonna due some star gazing.

I really do believe that there is a lot going on behind the scenes and one of these days we will be rewarded. Hopefully apabetalone will be a breakthru therapy for SARS Covid-19 as evidenced by the recent scientific publications in Cell. The human trials should be commencing any day. Here's to a successful trial in humans that yields miraculous results.

GLTA

Chicagoest

 

 

Share
New Message
Please login to post a reply